Johnson & Johnson (NYSE:JNJ) has put its stroke care business up for sale, aiming for a valuation of more than $1B, the Financial Times reported on Tuesday, citing people familiar with the matter.
Johnson & Johnson (NYSE:JNJ) has put its stroke care business up for sale, aiming for a valuation of more than $1B, the Financial Times reported on Tuesday, citing people familiar with the matter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback